These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 9815570

  • 1. p21 expression as a predictor for favorable prognosis in squamous cell carcinoma of the lung.
    Komiya T, Hosono Y, Hirashima T, Masuda N, Yasumitsu T, Nakagawa K, Kikui M, Ohno A, Fukuoka M, Kawase I.
    Clin Cancer Res; 1997 Oct; 3(10):1831-5. PubMed ID: 9815570
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
    Hirai K, Koizumi K, Haraguchi S, Hirata T, Mikami I, Fukushima M, Yamagishi S, Kawashima T, Okada D, Shimizu K, Kawamoto M.
    Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951
    [Abstract] [Full Text] [Related]

  • 3. p53, p21 and p27 protein expression in head and neck cancer and their prognostic value.
    Kapranos N, Stathopoulos GP, Manolopoulos L, Kokka E, Papadimitriou C, Bibas A, Yiotakis J, Adamopoulos G.
    Anticancer Res; 2001 Jan; 21(1B):521-8. PubMed ID: 11299798
    [Abstract] [Full Text] [Related]

  • 4. The 3' UTR IGF2R-A2/B2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer.
    Kotsinas A, Evangelou K, Sideridou M, Kotzamanis G, Constantinides C, Zavras AI, Douglass CW, Papavassiliou AG, Gorgoulis VG.
    Cancer Lett; 2008 Feb 08; 259(2):177-85. PubMed ID: 18037232
    [Abstract] [Full Text] [Related]

  • 5. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
    Mohamed S, Yasufuku K, Hiroshima K, Nakajima T, Yoshida S, Suzuki M, Sekine Y, Shibuya K, Iizasa T, Farouk A, Fujisawa T.
    Cancer; 2007 Jun 15; 109(12):2506-14. PubMed ID: 17487846
    [Abstract] [Full Text] [Related]

  • 6. Absence of prognostic significance of p21(WAF1/CIP1) protein expression in non-small cell lung cancer.
    Dworakowska D, Jassem E, Jassem J, Boltze C, Wiedorn KH, Dworakowski R, Skokowski J, Jaśkiewicz K, Czestochowska E.
    Acta Oncol; 2005 Jun 15; 44(1):75-9. PubMed ID: 15848909
    [Abstract] [Full Text] [Related]

  • 7. p21WAF1 expression is associated with improved survival after adjuvant chemoradiation for pancreatic cancer.
    Ahrendt SA, Brown HM, Komorowski RA, Zhu YR, Wilson SD, Erickson BA, Ritch PS, Pitt HA, Demeure MJ.
    Surgery; 2000 Oct 15; 128(4):520-30. PubMed ID: 11015084
    [Abstract] [Full Text] [Related]

  • 8. Expression of p53 and p21 is useful for the prediction of preoperative chemotherapeutic effects in esophageal carcinoma.
    Nakashima S, Natsugoe S, Matsumoto M, Kijima F, Takebayashi Y, Okumura H, Shimada M, Nakano S, Kusano C, Baba M, Takao S, Aikou T.
    Anticancer Res; 2000 Oct 15; 20(3B):1933-7. PubMed ID: 10928129
    [Abstract] [Full Text] [Related]

  • 9. Prognostic value of nuclear DNA content and expression of the ras oncogene product in lung cancer.
    Miyamoto H, Harada M, Isobe H, Akita HD, Haneda H, Yamaguchi E, Kuzumaki N, Kawakami Y.
    Cancer Res; 1991 Dec 01; 51(23 Pt 1):6346-50. PubMed ID: 1657384
    [Abstract] [Full Text] [Related]

  • 10. A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma.
    Tsai MF, Wang CC, Chang GC, Chen CY, Chen HY, Cheng CL, Yang YP, Wu CY, Shih FY, Liu CC, Lin HP, Jou YS, Lin SC, Lin CW, Chen WJ, Chan WK, Chen JJ, Yang PC.
    J Natl Cancer Inst; 2006 Jun 21; 98(12):825-38. PubMed ID: 16788156
    [Abstract] [Full Text] [Related]

  • 11. An immunohistochemical study of p16, pRb, p21 and p53 proteins in human esophageal cancers.
    Kato H, Yoshikawa M, Fukai Y, Tajima K, Masuda N, Tsukada K, Kuwano H, Nakajima T.
    Anticancer Res; 2000 Jun 21; 20(1A):345-9. PubMed ID: 10769678
    [Abstract] [Full Text] [Related]

  • 12. p53 and p21 Expression levels predict organ preservation and survival in invasive bladder carcinoma treated with a combined-modality approach.
    Garcia del Muro X, Condom E, Vigués F, Castellsagué X, Figueras A, Muñoz J, Solá J, Soler T, Capellà G, Germà JR.
    Cancer; 2004 May 01; 100(9):1859-67. PubMed ID: 15112266
    [Abstract] [Full Text] [Related]

  • 13. Neuroendocrine and biologic features of primary tumors and tissue in pulmonary large cell carcinomas.
    Ab' Saber AM, Massoni Neto LM, Bianchi CP, Ctenas BB, Parra ER, Eher EM, Pereira JC, Takagaki T, Yamaguchi NH, Capelozzi VL.
    Ann Thorac Surg; 2004 Jun 01; 77(6):1883-90. PubMed ID: 15172229
    [Abstract] [Full Text] [Related]

  • 14. The expression of cyclins D1 and E in predicting short-term survival in squamous cell carcinoma of the lung.
    Anton RC, Coffey DM, Gondo MM, Stephenson MA, Brown RW, Cagle PT.
    Mod Pathol; 2000 Nov 01; 13(11):1167-72. PubMed ID: 11106072
    [Abstract] [Full Text] [Related]

  • 15. Immunohistochemical characterization of p57KIP2 expression in human esophageal squamous cell carcinoma.
    Matsumoto M, Furihata M, Ohtsuki Y, Sasaguri S, Ogoshi S.
    Anticancer Res; 2000 Nov 01; 20(3B):1947-52. PubMed ID: 10928132
    [Abstract] [Full Text] [Related]

  • 16. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
    Choi HR, Tucker SA, Huang Z, Gillenwater AM, Luna MA, Batsakis JG, El-Naggar AK.
    Int J Oncol; 2003 Feb 01; 22(2):409-14. PubMed ID: 12527941
    [Abstract] [Full Text] [Related]

  • 17. Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer.
    Metzger R, Vallbohmer D, Müller-Tidow C, Higashi H, Bollschweiler E, Warnecke-Eberz U, Brabender J, Baldus SE, Xi H, Berdel WE, Serve H, Hoelscher AH, Schneider PM.
    Anticancer Res; 2009 Apr 01; 29(4):1157-62. PubMed ID: 19414359
    [Abstract] [Full Text] [Related]

  • 18. Skip metastasis in nonsmall cell lung carcinoma: predictive markers and isolated tumor cells in N1 lymph nodes.
    Prenzel KL, Baldus SE, Mönig SP, Tack D, Sinning JM, Gutschow CA, Grass G, Schneider PM, Dienes HP, Hölscher AH.
    Cancer; 2004 May 01; 100(9):1909-17. PubMed ID: 15112272
    [Abstract] [Full Text] [Related]

  • 19. Immunohistochemical study of cell cycle-associated proteins in adenocarcinoma of the uterine cervix treated with radiotherapy alone: P53 status has a strong impact on prognosis.
    Suzuki Y, Nakano T, Kato S, Ohno T, Tsujii H, Oka K.
    Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):231-6. PubMed ID: 15337561
    [Abstract] [Full Text] [Related]

  • 20. Expression of nucleolar protein p120 in human lung cancer: difference in histological types as a marker for proliferation.
    Uchiyama B, Saijo Y, Kumano N, Abe T, Fujimura S, Ohkuda K, Handa M, Satoh K, Nukiwa T.
    Clin Cancer Res; 1997 Oct 01; 3(10):1873-7. PubMed ID: 9815576
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.